CPRX
Price
$22.50
Change
-$0.16 (-0.71%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
2.77B
118 days until earnings call
Intraday BUY SELL Signals
NRIX
Price
$14.34
Change
+$1.66 (+13.09%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
1.45B
90 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CPRX vs NRIX

Header iconCPRX vs NRIX Comparison
Open Charts CPRX vs NRIXBanner chart's image
Catalyst Pharmaceuticals
Price$22.50
Change-$0.16 (-0.71%)
Volume$16.56K
Capitalization2.77B
Nurix Therapeutics
Price$14.34
Change+$1.66 (+13.09%)
Volume$27.67K
Capitalization1.45B
CPRX vs NRIX Comparison Chart in %
CPRX
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CPRX vs. NRIX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPRX is a Hold and NRIX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (CPRX: $22.50 vs. NRIX: $12.66)
Brand notoriety: CPRX and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CPRX: 72% vs. NRIX: 49%
Market capitalization -- CPRX: $2.77B vs. NRIX: $1.45B
CPRX [@Biotechnology] is valued at $2.77B. NRIX’s [@Biotechnology] market capitalization is $1.45B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPRX’s FA Score shows that 1 FA rating(s) are green whileNRIX’s FA Score has 1 green FA rating(s).

  • CPRX’s FA Score: 1 green, 4 red.
  • NRIX’s FA Score: 1 green, 4 red.
According to our system of comparison, CPRX is a better buy in the long-term than NRIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPRX’s TA Score shows that 4 TA indicator(s) are bullish while NRIX’s TA Score has 4 bullish TA indicator(s).

  • CPRX’s TA Score: 4 bullish, 4 bearish.
  • NRIX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CPRX is a better buy in the short-term than NRIX.

Price Growth

CPRX (@Biotechnology) experienced а -1.23% price change this week, while NRIX (@Biotechnology) price change was -1.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Reported Earning Dates

CPRX is expected to report earnings on Mar 18, 2026.

NRIX is expected to report earnings on Feb 18, 2026.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CPRX($2.77B) has a higher market cap than NRIX($1.45B). CPRX YTD gains are higher at: 7.810 vs. NRIX (-23.885). CPRX has higher annual earnings (EBITDA): 281M vs. NRIX (-248.7M). CPRX has more cash in the bank: 653M vs. NRIX (429M). CPRX has less debt than NRIX: CPRX (2.99M) vs NRIX (56.5M). CPRX has higher revenues than NRIX: CPRX (558M) vs NRIX (83.7M).
CPRXNRIXCPRX / NRIX
Capitalization2.77B1.45B190%
EBITDA281M-248.7M-113%
Gain YTD7.810-23.885-33%
P/E Ratio13.16N/A-
Revenue558M83.7M667%
Total Cash653M429M152%
Total Debt2.99M56.5M5%
FUNDAMENTALS RATINGS
CPRX: Fundamental Ratings
CPRX
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
21
SMR RATING
1..100
34
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
73
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CPRXNRIX
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 21 days ago
67%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
CPRX
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MBCNX17.40N/A
N/A
MassMutual Blue Chip Growth R3
TRGPX21.78N/A
N/A
Nuveen Quant Mid Cap Growth Premier
SDFSX18.12N/A
N/A
Sit Small Cap Dividend Growth S
VRTPX21.47N/A
N/A
Vanguard Real Estate II Index
ZEMAX14.59-0.03
-0.21%
American Beacon Ninety One Emr Mkts Eq Y

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with KYMR. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
+13.09%
KYMR - NRIX
64%
Loosely correlated
+0.95%
IDYA - NRIX
58%
Loosely correlated
-1.72%
DNLI - NRIX
57%
Loosely correlated
-3.20%
SYRE - NRIX
56%
Loosely correlated
+0.83%
TYRA - NRIX
55%
Loosely correlated
+3.55%
More